Springworks actions jump more than 30% in the news of the possible agreement

• Springworks Therapeutics shot out on Monday after a report that the German medical firm Merck Kgaa could acquire the company.

• An agreement could be announced between the German company and the manufacturer of cancer treatment with headquarters in the United States in the coming weeks, Reuters reported.

• Springworks actions jumped on Monday at their highest closing price in almost three years.

Springworks Therapeutics actions emerged on Monday in a report that a German medical technology giant could be close to acquiring the company.

Citing several people familiar with discussions, Reuters On Monday he informed that Springworks and Merck Kgaa, which appears in Germany, are in conversations and an agreement could be reached in the coming weeks. Reuters He later informed that Merck confirmed the “advanced” conversations.

Springworks (SWTX) It is developing several treatments for different types of cancers and tumors. Merck Kgaa, who announces himself as “the oldest pharmaceutical and chemical company in the world,” is a separate entity of the US pharmaceutical company with the same name.

Springworks actions ended Monday with 34% at its highest closure since April 2022, delivering some previous profits. Merck’s German actions finished the negotiation session of approximately 3%.

Merck has said that he is prepared to make new acquisitions after his cash reserves grew during pandemic in the middle of the growing demand for his products, Bloomberg reported.

A springworks spokesman declined to comment on the report. Merck did not immediately respond to a request for comments.

Read the original article in Inventopedia